BridgeBio Pharma, Inc. (BBIO)

64.50 -1.63 (-2.46%) USD  |  NASDAQ  |  May 18, 10:45
More

BridgeBio Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
Pfizer Inc. Upgrade
Insmed, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade